Congenital and inherited polycythemia

Current Opinion in Pediatrics

Volumn 12, Issue 1, 2000, Pages 29-34

  Kralovics, Robert ^a   Prchal, Josef T ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN VARIANT;

CONGENITAL DISORDER; ENZYME DEFECT; FAMILIAL DISEASE; GENE MUTATION; HEMATOCRIT; HUMAN; METHEMOGLOBINEMIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW;

2,3-DIPHOSPHOGLYCERATE; ADULT; BISPHOSPHOGLYCERATE MUTASE; CHILD; ERYTHROPOIETIN; HEMOGLOBINS, ABNORMAL; HUMANS; METHEMOGLOBINEMIA; POLYCYTHEMIA;

EID: 0033957582     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200002000-00006     Document Type: Review

References (49)

1. 1 Prchal J: Primary polycythemias. Curr Opinion Hematol 1995, 2:146-152.
2. 2 Emanuel P, Eaves C, Broudy V, Papayannopoulou T, Moore M, D' Andrea A, et al.: Familial and congenital polycythemia in three unrelated families. Blood 1992, 79:3019-3030.
3. 3 Juvonen E, Ikkala E, Fyhrquist F, Ruutu T: Autosomal dominant erythrocytosis causes by increased sensitivity to erythropoietin. Blood 1991, 78:3066-3069.
4. 4 Prchal J, Crist W, Goldwasser E, Perrine G, Prchal J: Autosomal dominant polycythemia. Blood 1985, 66:1208-1214.
5. 5 D'Andrea A, Lodish H, Wong G: Expression cloning of the murine erythropoietin receptor. Cell 1989, 57:277-285.
6. 6 Jones S, D'Andrea A, Haones L, Wong G: Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood 1990, 76:31-35.
7. 7 Winkelmann J, Penny L, Deaven L, Forget B, Jenkins R: The gene for the human erythropoietin receptor: Analysis of the coding sequence and assignment to chromosome 19q. Blood 1990, 76:24.
8. 8 De la Chapelle A, Sistonen P, Lehvaslaiho H, Ikkala H, Juvonen E: Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 1993, 341 :82-84.
9. 9 Sokol L, Prchal J: Two microsatellite repeat polymorphisms in the 5′ untranslated region of the erythropoietin receptor gene. Hum Mol Genet 1994, 3:219.
10. 10 De la Chapelle A, Traskelin A-L, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A 1993, 90:4495-4499.
11. 11 Sokol L, Prchal JF, D' Andrea AD, Rado TA, Prchal JT: Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Exp Hematol 1994, 22:447-453.
12. 12 Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT: Primary familial polycythemia: A frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 1995, 86:15-22.
13. 13 Kralovics R, Indrak K, Stopka T, Berman B, Prchal J, Prchal J: Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycylhemias. Blood 1997, 90:2057-2061.
14. 14 Kralovics R, Sokol L, Prchal JT: Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. J Clin Invest 1998, 102:124-129. In this report, the authors demonstrate that mutations of the erythropoeitin receptor may have various degree of phenotypic expression, and point out the existence of polythemia compensating factors.
15. 15 Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M, et al.: Primary familial polycythaemia associated with novel point mutation in the erythropoietin receptor. Br J Haematol 1997, 99:222-227.
16. 16 Kralovics R, Divoka M, Stopka T, Prchal JT: Low frequency of erythropoietin receptor gene mutations in subjects with primary familial and congenital polycythemia [abstract]. Blood 1997, 90:16.
17. 17 Arcasoy MO, Sinning JG, Segal HM, Forget BG: A novel mutation in the erythropoietin receptor (EPOR gene leads to an extensive COOH-terminal truncation of the EPOR associated with familial erythrocytosis) [abstract]. Blood 1998, 92:205.
18. 18 Le Couedic JP, Mitjavila MT, Villeval JL, Feger F, Gobert S, Mayeux P, et al.: Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood 1996, 87:1502-1511.
19. 19 Kralovics R, Sokol L, Broxson E, Prchal J: The erythropoietin receptor gene is not linked with polycythemia phenotype in a family with autosomal dominant primary polycythemia. Proc Assoc Am Physicians 1997, 109:580-585.
20. 20 D'Andrea A, Yoshimura A, Youssoufian H, Zon L, Koo J-W, Lodish H: The cytoplasmic region of the erythropoietin receptor contains non-overlapping positive and negative growth-regulatory domains. Mol Cell Biol 1991, 11:1980-1987.
21. 21 Witthuhn B, Quelle F, Silvennoinen O, Ul T, Tang B, Miura O, Ihle J: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993, 74:227-238.
22. 22 Klingmuller U, Lorenz U, Cantley L, Neel B, Lodish H: Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995, 80:729-738.
23. 23 Anagnostou A, Lee ES, Kesseimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 1990, 87:5978-5982.
24. 24 Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A 1994, 91:3974-3978.
25. 25 Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F, Tabira T, Sasaki R: Functional erythropoietin receptor of the cells with neural characteristics. J Biol Chem 1993, 268:11208-11216.
26. 26 Digicaylioglu M, Bichet S, Marti HH, Wegner RH, Rivas LA, Bauer C, Gassmann M: Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A 1995, 92:3717-3720.
27. 27 Prchal J, Semenza G, Prchal J, Sokol L: Familial Polycythemia. Science 1995, 268:1831-1832.
28. 28 Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L: Polycythemia vera: Stem cell and probable clonal origin of the disease. N Engl J Med 1976, 295:913-916.
29. 29 Fialkow PJ, Jacobson RJ, Papayannopoulou T: Chronic myelocytic leukemia: Clonaf origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977, 63:125-130.
30. 30 Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S: Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981, 58:916-919.
31. 31 El-Kassar N, Hetet G, Briere J, Grandchamp B: Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood 1997, 89:128-134.
32. 32 Anger B, Janssen JW, Schrezenmeier H, Hehlmann R, Heimpel H, Bartram CR: Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 1990, 4:258-261.
33. 33 Kreipe H, Jaquet K, Feigner J, Radzun HJ, Parwaresch MR: Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood 1991, 78:1814-1817.
34. 34 Diez-Martin JL, Graham DL, Petitt RM, Dewald GW: Chromosome studies in 104 patients with polycythemia vera. Mayo Clinic Proc 1991, 66:287.
35. 35 Kanfer E, Price CM, Colman SM, Barrett AJ: Erythropoietin-independent colony growth in polycythemia vera is not restricted to progenitor cells with trisomy of chromosome 8. Br J Haematol 1992, 82:773.
36. 36 Green AR: Pathogenesis of polycythemia vera. Lancet 1996, 349:844-845.
37. 37 Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A, Potter A: Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 1997, 98:96-102.
38. 38 Ratnoff WD, Gress RE: The familial occurrence of polycythemia vera: report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethylene. Blood 1980, 56:233-236.
39. 39 Perez-Encinas M, Bello JL, Perez-Crespo S, De Miguel R, Tome S: Familial myeloproliferative syndrome. Am J Hematol 1994, 46:225-229.
40. 40 Inaba T, Shimazaki C, Hirai H, Kikuta T, Sumikuma T, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N, Nakagawa M: Familial polycythemia vera in father and daughter. Am J Hematol 1996, 51:172.
41. 41 Miller RL, Purvis JD, Weick JK: Familial polycythemia vera. Cleve Clin J Med 1989, 56:813-818.
42. 42 Kralovics R, Gregg XT, DiMichele D, Smith SW Jr, Prchal JT: Polycythemia vera in three unrelated families [abstract]. Blood 1998, 92:425.
43. 43 Michiels JJ, Van Genderen PJ: Essential thrombocythemia in childhood. Semin Thromb Hemost 1997, 23:295-301.
44. 44 Prchal J, Axelrad A: Bone-marrow responses in polycythemia vera. N Eng J Med 1974, 289:132.
45. 45 Weinberg R: In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders. Semin Hem 1997, 34:64-69.
46. 46 Kralovics R, Prchal JT: Haematopoietic progenitors and signal transduction in polycythaemia vera and primary thrombocythaemia. Baillieres Clin Haematol 1998, 11:803-818. The authors of this report emphasize the differences between polycythemia vera and primary familial and congenital polycythemia, and also provide an overview of polycythemia vera and essential thrombocythemia.
47. 47 Lichtman M, Murphy M, Adamson J: Detection of mutant hemoglobins with altered affinity for oxygen: a simplified technique. Ann Intern Med 1976, 84:517-520.
48. 48 Galacteros F, Rosa R, Prehu M, Najean Y, Calvin M: Deficit en diphosphoglycerate mutase: nouveaux cas associes a une polyglobulie. Nouv Rev Fr Hematol 1982, 26:69,
49. 49 Sergeyeva A, Gordeuk V, Tokarev Y, Prchal J, Sokol L, Prchal J: Congenital polycythemia in Chuvashia. Blood 1993, 89:2148-2154.